Company Filing History:
Years Active: 2022
Title: Elisa Rojas Prats: Innovator in Neurological Treatments
Introduction
Elisa Rojas Prats is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of neurological treatments through her innovative research and development of pharmaceutical compounds. Her work focuses on addressing critical neurological conditions that affect millions of people worldwide.
Latest Patents
Elisa holds a patent for "CDC-7-inhibitor compounds and use thereof for the treatment of neurological conditions." This invention relates to a series of substituted purine derivatives capable of inhibiting CDC7 kinase activity. These compounds are suitable for treating neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and frontotemporal dementia. The invention targets the hyperphosphorylation of TDP-43 and the subsequent formation of aggregates induced by CDC7.
Career Highlights
Throughout her career, Elisa has worked with esteemed organizations, including the Consejo Superior de Investigaciones Científicas. Her research has been pivotal in advancing the understanding and treatment of neurological disorders. She has demonstrated a commitment to improving patient outcomes through her innovative approaches.
Collaborations
Elisa has collaborated with notable colleagues, including Ana Martinez Gil and Daniel I Perez. These partnerships have enriched her research and contributed to the development of her groundbreaking inventions.
Conclusion
Elisa Rojas Prats is a trailblazer in the field of neurological treatments, with her patent showcasing her dedication to addressing complex medical challenges. Her work continues to inspire advancements in the treatment of neurological conditions.